Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector
June 17, 2022
Mergers and Acquisitions
Kainan Zhang and Junting Lei of Haiwen & Partners highlight the main PRC foreign exchange regulatory requirements of different types of cross-border investment and trade by domestic and foreign individuals and institutions under capital and current accounts.
April 11, 20222021 regulatory trends in China, including antitrust, data privacy, sanctions, healthcare, PE/VC, capital markets, IP, banking & finance, TMT and arbitration.
February 09, 2022China joins the WIPO treaty on protecting industrial designs; Hong Kong, mainland M&A hits record heights in 2021 despite regulatory headwinds; and e-CNY to be piloted in retail shops across Hong Kong
February 08, 2022Fay Zhou and Arthur Peng of Linklaters review major developments in China's anti-trust regulations that aim to offer clearer guidance and more efficient enforcement actions that can impact on this area of law for the next decade. These developments include stronger deterrence, expanded substantive prohibitions, public interest litigation and a firmer stance against consolidation.
January 14, 2022With the entrenchment of reciprocal US-China sanctions and export controls in the past year, counsel have helped clients enact fundamental changes to their approach to making deals, from contractual terms to due diligence
January 14, 2022VIE overseas listings require government consent
January 14, 2022Foreign investors are allowed to conduct social surveys
January 14, 2022The U.S. adds 12 Chinese entities to its export blacklist; Rules regulating listed companies to be consolidated; Didi ordered by regulators to delist from NYSE
November 30, 2021Hong Kong finalizes secondary listing reforms to attract more Greater China Issuers; SAMR fines tech giants for failing to declare transactions; and German insurer Allianz approved to take full control of life insurance business
November 23, 2021
